Growing community of inventors

San Francisco, CA, United States of America

Tim Ingallinera

Average Co-Inventor Count = 6.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Tim IngallineraFritz Blatter (5 patents)Tim IngallineraJerry B Evarts (5 patents)Tim IngallineraTjeerd Barf (5 patents)Tim IngallineraEdwin Aret (5 patents)Tim IngallineraCecile Krejsa (5 patents)Tim IngallineraTim Ingallinera (5 patents)Fritz BlatterFritz Blatter (57 patents)Jerry B EvartsJerry B Evarts (27 patents)Tjeerd BarfTjeerd Barf (23 patents)Edwin AretEdwin Aret (14 patents)Cecile KrejsaCecile Krejsa (10 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Acerta Pharma B.v. (5 from 21 patents)


5 patents:

1. 11820777 - Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

2. 11059829 - Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide maleate

3. 10640509 - Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma

4. 10167291 - Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

5. 9796721 - [object Object]

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…